Periodic monitoring Active

Key facts

  • Consultation rates for respiratory illness in both primary and secondary care settings are increasing in some Member States, yet remain at baseline levels across all EU/EEA countries, except for Denmark and Spain, which reported low activity in primary care settings.
  • SARS-CoV-2activity is increasing slightly in primary care and has also increased in secondary care in comparison to last week. Detections in primary care are mainly related to individuals aged 15 years and above, while in secondary care they primarily concern adults aged over 65 years.
  • Influenza virus activity is at baseline levels overall, with only a few countries reporting detections in primary or secondary care. Detections in secondary care have slightly increased in comparison to last week and mainly concern adults aged over 65 years. Most detections are influenza A viruses.
  • Respiratory syncytial virus (RSV) activity is low and at expected inter-epidemic levels.

Overview

ECDC monitors respiratory illness rates and virus activity across the EU/EEA. Findings are presented in the European Respiratory Virus Surveillance Summary (ERVISS.org), which is updated weekly.

Key visualisation from the weekly bulletin are included below.

All data are provisional and may be affected by reporting delays, incomplete country data or low testing volumes. A few countries with high testing rates can disproportionately influence pooled data. Further information is available under ‘Country notes’ and ‘Additional resources’.

Visualisations

Figure 1. ILI/ARI virological surveillance in primary care - weekly test positivity

Figure 2. SARI virological surveillance in hospitals - weekly test positivity

Figure 3. Key indicators

Figure 4. ILI/ARI virological surveillance in primary care - pathogen type and subtype distribution

Figure 5. SARI virological surveillance in hospitals - pathogen type and subtype distribution

Figure 6. Genetically characterised influenza virus distribution, week 40, 2025 – week 39, 2026

Figure 7. SARS-CoV-2 variant distribution, week 37, 2026 - week 38, 2026

Latest updates for this event

View all